Calcitriol-induced apoptosis in LNCaP cells is blocked by overexpression of Bcl-2

Endocrinology

Volumn 141, Issue 1, 2000, Pages 10-17

  Blutt, Sarah E ^a   Mcdonnell, Timothy J ^b   Polek, Tara C ^a   Weigel, Nancy L ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCITRIOL; PROTEIN BAX; PROTEIN BCL 2; PROTEIN BCL X; PROTEIN BCL XL; PROTEIN MCL 1; UNCLASSIFIED DRUG; VITAMIN D; VITAMIN D RECEPTOR;

APOPTOSIS; ARTICLE; BONE METABOLISM; CANCER GROWTH; CELL DIFFERENTIATION; CONTROLLED STUDY; GENE OVEREXPRESSION; GROWTH INHIBITION; HUMAN; HUMAN CELL; MINERAL METABOLISM; PRIORITY JOURNAL;

EID: 0034463114     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/endo.141.1.7289     Document Type: Article

References (52)

1. The prostate: An increasing medical problem
2. Epidemiologic evidence regarding predisposing factors to prostate cancer
3. Vitamin D: A modulator of cell proliferation and differentiation
4. A unified nomenclature system for the nuclear receptor superfamily
5. Retinoic acid receptors and cellular retinoid binding proteins: Complex interplay in retinoid signaling
6. Molecular cloning of complementary DNA encoding the avian receptor for vitamin D
7. 3 receptors and actions in human prostate cancer cell lines
8. 3 in seven human prostatic carcinoma cell lines
9. 3 are mediated exclusively through the genomic signaling pathway
10. 3 in the human prostatic carcinoma cell line ALVA-31
11. Vitamin D receptor content and transcriptional activity do not fully predict antiproliferative effects of vitamin D in human prostate cancer cell lines
12. 1
13. 3 and the regulation of human cancer cell replication
14. 3 induces morphological and biochemical markers of apoptosis in MCF-7 breast cancer cells
15. 3, transforming growth factor β1, calcium, and ultraviolet B radiation induce apoptosis in cultured human keratinocytes
16. 3 derivatives on growth, differentiation and apoptosis in tumoral colonic HT29 cells: Possible implication of intracellular calcium
17. 3 and its analogues on induction of apoptosis in breast cancer cells
18. 3 analogues: A novel class of potent inhibitors of proliferation and inducers of differentiation of human breast cancer cell lines
19. 1 accumulation
20. 3 on proliferation of cancer cells in vitro
21. 3 in androgen-responsive LNCaP cells
22. Importance of the bcl-2 family in cell death regulation
23. Cell death signal transduction and bcl-2 function
24. Immunohistochemical analysis of bcl-2, bax, bcl-X, and mcl-1 expression in prostate cancer
25. Immunocytochemical localization of BCL-2 protein in human breast cancers and its relationship to a series of prognostic markers and response to endocrine therapy
26. Small cell carcinomas of the lung express the Bcl-2 protein
27. p53 oncogene mutations in three human prostate cancer cell lines
28. Androgen receptor gene expression in human prostate carcinoma cell lines
29. LNCaP model of human prostatic carcinoma
30. Suppression of tumorigenicity of human prostate carcinoma cells by replacing a mutated Rb gene
31. Tumour suppressor genes in prostate cancer
32. Regulation of lipid signaling pathways for cell survival and apoptosis by bcl-2 in prostate carcinoma cells
33. Bcl-2 inhibits p53 nuclear import following DNA damage
34. A rapid and sensitive method for quantification of microgram quantities of protein utilizing the principle of protein-dye binding
35. Detection of DNA strand breaks in individual apoptotic cells by the in situ terminal deoxynucleotidyl transferase and nick translation assays
36. Phorbol ester-induced apoptosis is accompanied by NGFI-A and c-fos activation in androgen-sensitive prostate cancer cells
37. 3 receptor and other nonreceptor transcription factors
38. Overexpression of bcl-2 protects prostate cancer cells from apoptosis in vitro and confers resistance to androgen depletion in vivo
39. Bcl-2 over-expression delays radiation-induced apoptosis without affecting clonogenic survival of human prostate cancer cells
40. Production of a mouse monoclonal antibody reactive with a human nuclear antigen associated with cell proliferation
41. 3
42. 3 and EB 1089 on cell cycle kinetics and apoptosis in MCF-7 breast cancer cells
43. 3 protects HL60 cells against apoptosis but down-regulates the expression of the bcl-2 gene
44. Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death
45. Human prostate cancer cells: Inhibition of proliferation by vitamin D analogs
46. 3 analogs: A unique class of potent inhibitors of proliferation of prostate, breast, and hematopoietic cancer cells
47. 3 analogs on clonal proliferation of human prostate cancer cell lines
48. 3 to inhibit growth of DU 145 human prostate cancer cells by blocking 24-hydroxylase activity
49. 3 actions in LNCaP human prostate cancer cells are androgen-dependent
50. Detection of the apoptosis-suppressing oncoprotein bcl-2 in hormone-refractory human prostate cancer
51. Expression of the protooncogene bcl-2 in the prostate and its association with emergence of androgen-independent prostate cancer
52. Development of a hammerhead ribozyme against BCL-2. II. Ribozyme treatment sensitizes hormone-resistant prostate cancer cells to apoptotic agents